Mitogen-activated protein kinase phosphatase-1 (MKP-1) impairs the response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab in metastatic colorectal cancer patients
作者： C Montagut , M Iglesias , M Arumi , B Bellosillo , M Gallen
关键词: Proto-Oncogene Proteins B-raf 、 Metastasis 、 Growth factor receptor 、 Internal medicine 、 Cancer 、 Endocrinology 、 Cancer research 、 Cetuximab 、 EGFR Antibody 、 Protein kinase A 、 Medicine 、 Epidermal growth factor receptor
摘要: Mitogen-activated protein kinase phosphatase-1 (MKP-1) impairs the response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab in metastatic colorectal cancer patients
nature.com
sci-hub.se 参考文章(58)
W. De Roock, M. Janssens, B. Biesmans, B. Jacobs, J. De Schutter, S. Fieuws, E. Van Cutsem, S. Tejpar, DUSPs as markers of MEK/Erk activation in primary colorectal cancer Journal of Clinical Oncology. ,vol. 27, pp. 4064- 4064 ,(2009) , 10.1200/JCO.2009.27.15_SUPPL.4064
Christopher Corless, Massimo Loda, Cristina Magi-Galluzzi, Walter Grigioni, Philip J.S. Stork, Youbin Wang, Hong Yao, Rajesh Mishra, Paola Capodieci, Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis. American Journal of Pathology. ,vol. 149, pp. 1553- 1564 ,(1996)
Kenji Takeuchi, Tomohiro Shin-ya, Kazuto Nishio, Fumiaki Ito, Mitogen-activated protein kinase phosphatase-1 modulated JNK activation is critical for apoptosis induced by inhibitor of epidermal growth factor receptor-tyrosine kinase. FEBS Journal. ,vol. 276, pp. 1255- 1265 ,(2009) , 10.1111/J.1742-4658.2008.06861.X
Kenji Takeuchi, Fumiaki Ito, EGF receptor in relation to tumor development: molecular basis of responsiveness of cancer cells to EGFR‐targeting tyrosine kinase inhibitors FEBS Journal. ,vol. 277, pp. 316- 326 ,(2010) , 10.1111/J.1742-4658.2009.07450.X
Yun-Wei Lin, Jia-Ling Yang, Cooperation of ERK and SCFSkp2 for MKP-1 Destruction Provides a Positive Feedback Regulation of Proliferating Signaling Journal of Biological Chemistry. ,vol. 281, pp. 915- 926 ,(2006) , 10.1074/JBC.M508720200
Huanjie Yang, Gen Sheng Wu, p53 Transactivates the phosphatase MKP1 through both intronic and exonic p53 responsive elements. Cancer Biology & Therapy. ,vol. 3, pp. 1277- 1282 ,(2004) , 10.4161/CBT.3.12.1370
F Di Fiore, F Blanchard, F Charbonnier, F Le Pessot, A Lamy, M P Galais, L Bastit, A Killian, R Sesboüé, J J Tuech, A M Queuniet, B Paillot, J C Sabourin, F Michot, P Michel, T Frebourg, Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy. British Journal of Cancer. ,vol. 96, pp. 1166- 1169 ,(2007) , 10.1038/SJ.BJC.6603685
Carolyn D. Seib, Flavio G. Rocha, Dick G. Hwang, Brent T. Shoji, Gastrosplenic Fistula From Hodgkin's Lymphoma Journal of Clinical Oncology. ,vol. 27, ,(2009) , 10.1200/JCO.2008.21.7695
J. Wang, J.-Y. Zhou, G. S. Wu, ERK-Dependent MKP-1–Mediated Cisplatin Resistance in Human Ovarian Cancer Cells Cancer Research. ,vol. 67, pp. 11933- 11941 ,(2007) , 10.1158/0008-5472.CAN-07-5185
U. McDermott, S. V. Sharma, L. Dowell, P. Greninger, C. Montagut, J. Lamb, H. Archibald, R. Raudales, A. Tam, D. Lee, S. M. Rothenberg, J. G. Supko, R. Sordella, L. E. Ulkus, A. J. Iafrate, S. Maheswaran, C. N. Njauw, H. Tsao, L. Drew, J. H. Hanke, X.-J. Ma, M. G. Erlander, N. S. Gray, D. A. Haber, J. Settleman, Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling Proceedings of the National Academy of Sciences of the United States of America. ,vol. 104, pp. 19936- 19941 ,(2007) , 10.1073/PNAS.0707498104